1.The Prevalence of Helicobacter pylori Infection in Korean Patients with Inflammatory Bowel Disease, a Multicenter Study.
Min Jun SONG ; Dong Il PARK ; Sang Jun HWANG ; Eun Ran KIM ; Young Ho KIM ; Byeong Ik JANG ; Suck Ho LEE ; Jeong Seon JI ; Sung Jae SHIN
The Korean Journal of Gastroenterology 2009;53(6):341-347
BACKGROUND/AIMS: The prevalence of Helicobacter pylori (H. pylori) infection has been reported to be lower in individuals with inflammatory bowel disease (IBD) in some Western countries. We investigated H. pylori infection in Korean patients with IBD and any possible associations of H. pylori infection with drug therapy for IBD and the phenotype of Crohn's disease (CD). METHODS: We studied 316 unselected patients with IBD, including 169 ulcerative colitis (UC) patients and 147 with CD, and the control group consisted of 316 age- and gender-matched healthy people who received a comprehensive medical examination for a regular checkup purpose. Infection rates of H. pylori as detected by the urea breath test were compared between the IBD patients and the controls. RESULTS: A statistically significant difference in H. pylori infection rate was noticed between the IBD patients (25.3%) and the controls (52.5%; p<0.001), and between UC (32.0%) and CD patients (17.7%; p=0.04). Among the IBD patients, the age group of <60 and individuals with a history of taking metronidazole (13.0%; p=0.038) or ciprofloxacin (6.7%; p=0.001) were found to have a meaningfully lower infection rate, but those who did not take antibiotics still showed H. pylori infection rate significantly lower than the controls (CD 22.0% vs. UC 33.8% vs. Control 52.5%, p<0.001). With an exception of age, phenotypic characteristics showed no significant relations with H. pylori infection rate in CD patients. CONCLUSIONS: Korean patients with IBD, particularly CD, were found to have a significantly lower H. pylori infection rate than the controls. This association was more evident in those <60 years old, which suggested that H. pylori infection might be deemed to lower possible risks of IBD in younger adults.
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Colitis, Ulcerative/complications/diagnosis/drug therapy
;
Crohn Disease/complications/diagnosis/drug therapy
;
Female
;
Helicobacter Infections/complications/diagnosis/*epidemiology
;
*Helicobacter pylori
;
Humans
;
Inflammatory Bowel Diseases/*complications/diagnosis/drug therapy
;
Korea
;
Male
;
Middle Aged
;
Phenotype
;
Prevalence
2.Prognostic analysis of children with Henoch-Schonlein purpura treated by Helicobacter pylori eradication therapy.
Hua-Bo CAI ; Yong-Bai LI ; Hui ZHAO ; Shao-Ming ZHOU ; Xiao-Dong ZHAO
Chinese Journal of Contemporary Pediatrics 2014;16(3):234-237
OBJECTIVETo investigate the effect of Helicobacter pylori (Hp) eradication therapy on prognosis in children with Henoch-Schonlein purpura (HSP).
METHODSA total of 153 children with HSP were divided into Hp infection treatment group (n=22), Hp infection control group (n=21), and Hp infection-negative group (n=110). The Hp infection treatment group received one-week triple therapy for Hp eradication in addition to conventional treatment, while the Hp infection control group and Hp infection-negative group received conventional treatment. All patients were followed up for prognostic evaluation.
RESULTSThe response rates of the Hp infection treatment, control, and negative groups were 86% (19/22), 90% (19/21) and 85% (94/110), respectively (P>0.05). The recurrence rates of HSP in the Hp infection treatment, control, and negative groups were 14% (3/22), 24% (5/21) and 31% (34/110), respectively (P>0.05). The incidence of Henoch-Schonlein purpura nephritis (HSPN) in the Hp infection-negative group (36%, 40/110) and control group (33%, 7/21) was significantly higher than that in the Hp infection treatment group (5%, 1/22) (P<0.05 for both), but no significant difference in the incidence of HSPN was found between the control and negative groups (P>0.05).
CONCLUSIONSOne-week triple therapy for Hp eradication may be useful to reduce the incidence of HSPN in children with HSP infected with Hp.
Child ; Child, Preschool ; Female ; Helicobacter Infections ; complications ; drug therapy ; Helicobacter pylori ; Humans ; Incidence ; Male ; Prognosis ; Purpura, Schoenlein-Henoch ; epidemiology ; etiology ; Recurrence
3.Clinical Characteristics of Gastroesophageal Reflux Diseases and Association with Helicobacter pylori Infection.
Byung Chang KIM ; Young Hoon YOON ; Hyun Soo JYUNG ; Jae Bock CHUNG ; Chae Yun CHON ; Sang In LEE ; Yong Chan LEE
The Korean Journal of Gastroenterology 2006;47(5):363-369
BACKGROUND/AIMS: The prevalence of gastroesophageal reflux disease (GERD) in Korea was believed to be low until now. Korea is now believed to be on the evolving stage of GERD in its' prevalence. The aims of this study were to evaluate the epidemiologic and clinicopathologic characteristics among the subgroups of GERD i.e. non-erosive GERD (NERD), erosive GERD (ERD) and Barrett's esophagus (BE), and the role of Helicobacter pylori (H. pylori) infection in the pathogenesis of GERD. METHODS: A total of 253 patients with typical symptoms of GERD who underwent EGD were enrolled from October 2002 to January 2004. Patients were grouped as NERD, ERD or BE based on the symptoms and endoscopic findings. BE was histologically confirmed if necessary. Various clinical parameters including the status of H. pylori infection were analyzed. RESULTS: Among 253 patients, 106 patients were classified as NERD while 116 and 31 patients were classified as ERD and BE group respectively. BE and ERD group showed no gender predilection while NERD showed female preponderance (2.31:1, p<0.05). NERD group were younger (49.57 y.o.) than BE (57.87 y.o.) and ERD (52.30 y.o.) group. About three quarters of the patients of erosive esophagitis were LA-A (74.2%) grade. This suggests the mild nature of erosive esophagitis in Korea. ERD showed significantly higher BMI (kg/m2) compared to NERD (p<0.05). Hiatal hernia was frequently associated with BE and ERD (p<0.05), but less frequently in NERD. Overall H. pylori positivity among GERD was significantly lower than the age and gender matched control group (p<0.05). CONCLUSIONS: Subgroups of GERD in Korea showed different epidemiologic and clinical characteristics. Lower rate of H. pylori infection among GERD group may reflect the protective role of H. pylori infection regarding GERD prevalence in Korea.
Aged
;
Barrett Esophagus/diagnosis/drug therapy/microbiology
;
Female
;
Gastroesophageal Reflux/diagnosis/drug therapy/*microbiology
;
Helicobacter Infections/*complications/drug therapy/epidemiology
;
*Helicobacter pylori
;
Humans
;
Korea/epidemiology
;
Male
;
Middle Aged
;
Prevalence
4.Changes in Upper Gastrointestinal Diseases according to Improvement of Helicobacter pylori Prevalence Rate in Korea.
The Korean Journal of Gastroenterology 2015;65(4):199-204
Helicobacter pylori can cause variety of upper gastrointestinal disorders such as peptic ulcer, mucosa associated lymphoid tissue (MALT)-lymphoma, and gastric cancer. The prevalence of H. pylori infection has significantly decreased in Korea since 1998 owing to active eradication of H. pylori. Along with its decrease, the prevalence of peptic ulcer has also decreased. However, the mean age of gastric ulcer increased and this is considered to be due to increase in NSAID prescription. Gastric cancer is one of the leading causes of cancer deaths in Korea and Japan, and IARC/WHO has classified H. pylori as class one carcinogen of gastric cancer. Despite the decreasing prevalence of H. pylori infection, the total number of gastric cancer in Korea has continuously increased from 2006 to 2011. Nevertheless, the 5 year survival rate of gastric cancer patients significantly increased from 42.8% in 1993 to 67% in 2010. This increase in survival rate seems to be mainly due to early detection of gastric cancer and endoscopic mucosal dissection treatment. Based on these findings, the prevalence of peptic ulcer is expected to decrease even more with H. pylori eradication therapy and NSAID will become the main cause of peptic ulcer. Although the prevalence of gastric cancer has not changed along with decreased the prevalence of H. pylori, gastric cancer is expected to decrease in the long run with the help of eradication therapy and endoscopic treatment of precancerous lesions.
Anti-Bacterial Agents/therapeutic use
;
Anti-Inflammatory Agents, Non-Steroidal/adverse effects
;
Gastrointestinal Diseases/complications/*epidemiology
;
Helicobacter Infections/complications/drug therapy/epidemiology
;
Humans
;
Lymphoma, B-Cell, Marginal Zone/epidemiology
;
Peptic Ulcer/epidemiology/etiology
;
Prevalence
;
Stomach Neoplasms/etiology/mortality/pathology
5.Helicobacter pylori Eradication within 120 Days Is Associated with Decreased Complicated Recurrent Peptic Ulcers in Peptic Ulcer Bleeding Patients.
Shen Shong CHANG ; Hsiao Yun HU
Gut and Liver 2015;9(3):346-352
BACKGROUND/AIMS: The connection between Helicobacter pylori and complicated peptic ulcer disease in peptic ulcer bleeding (PUB) patients taking nonsteroidal anti-inflammatory drugs has not been established. In this study, we sought to determine whether delayed H. pylori eradication therapy in PUB patients increases complicated recurrent peptic ulcers. METHODS: We identified inpatient PUB patients using the Taiwan National Health Insurance Research Database. We categorized patients into early (time lag < or =120 days after peptic ulcer diagnosis) and late H. pylori eradication therapy groups. The Cox proportional hazards model was used. The primary outcome was rehospitalization for patients with complicated recurrent peptic ulcers. RESULTS: Our data indicated that the late H. pylori eradication therapy group had a higher rate of complicated recurrent peptic ulcers (hazard ratio [HR], 1.52; p=0.006), with time lags of more than 120 days. However, our results indicated a similar risk of complicated recurrent peptic ulcers (HR, 1.20; p=0.275) in time lags of more than 1 year and (HR, 1.10; p=0.621) more than 2 years. CONCLUSIONS: H. pylori eradication within 120 days was associated with decreased complicated recurrent peptic ulcers in patients with PUB. We recommend that H. pylori eradication should be conducted within 120 days in patients with PUB.
Adult
;
Aged
;
Female
;
Helicobacter Infections/*drug therapy
;
*Helicobacter pylori
;
Humans
;
Male
;
Middle Aged
;
Patient Readmission/*statistics & numerical data
;
Peptic Ulcer/complications/*epidemiology/microbiology
;
Peptic Ulcer Hemorrhage/complications
;
Proportional Hazards Models
;
Recurrence
;
Time-to-Treatment/*statistics & numerical data
;
Treatment Outcome
;
Young Adult
6.A Multicenter Retrospective Analysis of the Clinical Features of Pernicious Anemia in a Korean Population.
Ik Chan SONG ; Hyo Jin LEE ; Han Jo KIM ; Sang Byung BAE ; Kyu Taek LEE ; Young Jun YANG ; Suk Young PARK ; Do Yeun CHO ; Nae Yu KIM ; In Sung CHO ; Deog Yeon JO
Journal of Korean Medical Science 2013;28(2):200-204
To determine the approximate incidence and clinical features of pernicious anemia in a Korean population, we retrospectively analyzed clinical data for patients with pernicious anemia who were diagnosed between 1995 and 2010 at five hospitals in Chungnam province. Ninety-seven patients were enrolled, who accounted for 24% of patients with vitamin B12 deficiency anemia. The approximate annual incidence of pernicious anemia was 0.3 per 100,000. The median age was 66 (range, 32-98) yr, and the male/female ratio was 1.25. Anemia-associated discomfort was the most common symptom (79.4%), followed by gastrointestinal and neurological symptoms (78.4% and 38.1%, respectively). Pancytopenia was found in 36 patients (37.1%), and autoimmune disorders were found in 15 patients (15.5%). Antibody to intrinsic factor was detected in 62 (77.5%) of 80 patients examined, and antibody to parietal cells was detected in 35 (43.2%) of 81 patients examined. Of the 34 patients who underwent tests for Helicobacter pylori, 7 (12.5%) were positive. The anemia-associated and gastrointestinal symptoms resolved completely in all patients after intramuscular injection of cobalamin, whereas neurological symptoms remained in some. In conclusion, pernicious anemia is less frequent in Koreans than in Western populations; however, the clinical features of this disorder in Koreans do not differ from those of Western cases.
Adult
;
Aged
;
Anemia, Pernicious/complications/*diagnosis/epidemiology
;
Asian Continental Ancestry Group
;
Autoimmune Diseases/complications/epidemiology
;
Female
;
Gastrointestinal Diseases/complications/drug therapy/epidemiology
;
Helicobacter Infections/diagnosis
;
Helicobacter pylori
;
Humans
;
Isoantibodies/blood
;
Male
;
Middle Aged
;
Nervous System Diseases/complications/epidemiology
;
Parietal Cells, Gastric/immunology
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Vitamin B 12/blood/therapeutic use
7.The Effect of Aspirin Alone or Aspirin Plus Additional Antiplatelets Therapy on Upper Gastrointestinal Hemorrhage.
Suh Eun BAE ; Seong Eun KIM ; Sung Ae JUNG ; So Yoon YOON ; Ki Nam SHIM ; Hye Kyung JUNG ; Tae Hun KIM ; Kwon YOO ; Il Hwan MOON
The Korean Journal of Gastroenterology 2011;57(4):213-220
BACKGROUND/AIMS: The increasing incidence of cardiovascular disease has led to an increase in the frequency of upper gastrointestinal (GI) hemorrhage due to the use of antiplatelet agents. This study examined the clinical characteristics of patients with upper GI hemorrhage who were administered aspirin alone or a combination treatment of antiplatelet agents. METHODS: A 656 patients who underwent drug-eluting coronary stenting at Ewha Mokdong Hospital in 2008 were divided into three groups according to the antiplatetlet agents used after the intervention; groups of aspirin alone, aspirin plus clopidogrel, and aspirin, and clopidogrel plus another antiplatelet agent, respectively. Patients admitted with GI hemorrhage in the same period without a medication history of antiplatelet or nonsteroidal anti-inflammatory drugs were used as the control hemorrhage group. The medical records were reviewed. RESULTS: Significant GI symptoms were observed in 21.1% of total patients, of whom 48.2% had ulcers. The upper GI hemorrhage rate was 3.8%. There was no significant difference in the hemorrhage rate between three groups. Compared to the control hemorrhage group, the endoscopic variables of the antiplatelet-related hemorrhage group were not significantly different. However, the Helicobacter pylori infection rate was lower, the admission period was longer, and the mortality rate was higher in the antiplatelet-related hemorrhage group (p<0.05, respectively). There was no direct association between restarting or discontinuance of antiplatelets after the hemorrhage event and mortality. CONCLUSIONS: Adding other antiplatelet agents to aspirin did not increase the hemorrhage rate. However, active diagnostic and therapeutic efforts are recommended in patients with GI symptoms during antiplatelet therapy.
Aged
;
Aspirin/*adverse effects/therapeutic use
;
Cardiovascular Diseases/prevention & control
;
Drug Therapy, Combination
;
Drug-Eluting Stents
;
Endoscopy, Gastrointestinal
;
Female
;
Gastrointestinal Hemorrhage/*chemically induced/mortality/prevention & control
;
Helicobacter Infections/complications/epidemiology
;
Helicobacter pylori
;
Humans
;
Male
;
Middle Aged
;
Peptic Ulcer/complications/epidemiology
;
Platelet Aggregation Inhibitors/*adverse effects/therapeutic use
;
Retrospective Studies
;
Risk Factors
;
Ticlopidine/adverse effects/analogs & derivatives/therapeutic use
8.Primary Antibiotic Resistance of Helicobacter pylori Strains and Eradication Rate according to Gastroduodenal Disease in Korea.
Jae Yeon KIM ; Nayoung KIM ; Hyun Kyung PARK ; Hyun Jin JO ; Cheol Min SHIN ; Sang Hyub LEE ; Young Soo PARK ; Jin Hyeok HWANG ; Jin Wook KIM ; Sook Hyang JEONG ; Dong Ho LEE ; Ryoung Hee NAM ; Jung Mogg KIM ; Ji Hyun LEE ; Hyun Chae JUNG ; In Sung SONG
The Korean Journal of Gastroenterology 2011;58(2):74-81
BACKGROUND/AIMS: This study was performed to evaluate whether the prevalence rates of primary antibiotic resistance in Helicobacter pylori (H. pylori) isolates and the eradication rate of H. pylori could be different between cancer and non-cancer patients. METHODS: H. pylori were isolated from gastric mucosal biopsy specimens obtained from 269 Koreans, who did not have any eradication therapy history and were diagnosed as one of the following diseases; chronic gastritis, benign gastric ulcer, duodenal ulcer or gastric cancer. The susceptibilities of the H. pylori isolates to amoxicillin, clarithromycin, metronidazole, tetracycline, azithromycin, ciprofloxacin, levofloxacin and moxifloxacin were examined with the agar dilution method. In addition, eradication rate of H. pylori was evaluated. RESULTS: There was no significant difference in the primary antibiotic resistance to above eight antibiotics among chronic gastritis, peptic ulcer disease and gastric cancer. Furthermore there was no difference of antibiotic resistance between cancer and non-cancer patients, and there was no difference of eradication rate of H. pylori according to disease. CONCLUSIONS: Primary antibiotic resistance and H. pylori eradication rate were not different between cancer and non-cancer patients.
2-Pyridinylmethylsulfinylbenzimidazoles/therapeutic use
;
Adult
;
Aged
;
Amoxicillin/therapeutic use
;
Anti-Bacterial Agents/therapeutic use
;
Chronic Disease
;
Clarithromycin/therapeutic use
;
*Drug Resistance, Bacterial
;
Drug Therapy, Combination
;
Duodenal Ulcer/complications/microbiology
;
Female
;
Gastritis/complications/microbiology
;
Helicobacter Infections/drug therapy/*epidemiology/microbiology
;
Helicobacter pylori/*drug effects/isolation & purification
;
Humans
;
Male
;
Microbial Sensitivity Tests
;
Middle Aged
;
Omeprazole/therapeutic use
;
Peptic Ulcer/complications/microbiology
;
Proton Pump Inhibitors/therapeutic use
;
Republic of Korea
;
Stomach Neoplasms/complications/microbiology
9.Clinical Characteristics of Patients Diagnosed as Peptic Ulcer Disease in the Third Referral Center in 2007.
Jin Joo KIM ; Nayoung KIM ; Hyun Kyung PARK ; Hyun Jin JO ; Cheol Min SHIN ; Sang Hyup LEE ; Young Soo PARK ; Jin Hyeok HWANG ; Jin Wook KIM ; Sook Hyang JEONG ; Dong Ho LEE ; Jung Mogg KIM ; Ji Hyun LEE ; Hyun Chae JUNG ; In Sung SONG
The Korean Journal of Gastroenterology 2012;59(5):338-346
BACKGROUND/AIMS: In spite of the improvement of medical treatment for the peptic ulcer disease (PUD), PUD is still one of the common upper gastrointestinal diseases. The purpose of this study was to evaluate the risk factors and general characteristics of Korean patients diagnosed as PUD at a single third referral center. METHODS: A total of 310 patients, diagnosed as PUD through endoscopy during one year of 2007 at Seoul National University Bundang Hospital were, retrospectively, evaluated regarding age, gender, Helicobacter pylori (H. pylori) positivity, clinical manifestations, comorbidities and medications. In addition, PUD was analyzed in the aspect of ulcer location, type of visit, gastrointestinal bleeding, and age. RESULTS: The mean age was 61.5 years old (48.1% over 65) and 208 (66.7%) patients were men. The rate of H. pylori infection was 47.8%, and any ulcerogenic medication history such as antiplatelet agents and NSAIDs was found to be 21.0% (65 patients). The rate of idiopathic peptic ulcer without evidence of H. pylori and NSAIDs was found to be 40.6% (126 patients). Among 310 PUD patients, bleeding symptoms such as melena, hematemesis and hematochezia occurred in 110 patients (35.5%). CONCLUSIONS: PUD was more prevalent in the elderly patients and frequently associated with bleeding. Substantial proportion of PUD patients had neither H. pylori infection nor history of ulcerogenic medications, suggesting of increasing prevalence of idiopathic PUD.
Adult
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
;
Female
;
Gastrointestinal Hemorrhage
;
Gastroscopy
;
Helicobacter Infections/complications/diagnosis
;
Helicobacter pylori
;
Hematemesis
;
Humans
;
Male
;
Melena
;
Middle Aged
;
Peptic Ulcer/*diagnosis/drug therapy/epidemiology
;
Platelet Aggregation Inhibitors/therapeutic use
;
Prevalence
;
Referral and Consultation
;
Retrospective Studies
;
Risk Factors
;
Sex Factors